Dr. P V Ramana

Dr. P V Ramana

Primary Speciality : Neuro Surgery

Secondary Speciality : General Surgery

Qualification :  MBBS, MNAMS, FELLOW OF MICRONEUROSURGERY, FELLOW OF AMERICAN COLLEGE OF SURGEONS, FELLOW OF INTERNATIONAL COLLEGE OF SURGEONS, FELLOW OF SPINE SURGERY, FELLOW OF MINIMALLY INVASIVE NEUROSURGERY, INTERNATIONAL OBSERVER SPINAL SURGERY, DNB

Location : Visakhapatnam, India

Verified

BIOGRAPHICAL SKETCH

Senior neurosurgeon with experience of more than 26 years.Trained at the top institutes of world like Prof B Ramamuthi,Chennai,CMC Vellore,Bombay Hospital,Cleveland Clinic, Holland, France, Japan, South Korea and England. Developed the first neurosurgical team which is more than 20 years old and has high success rate .Completed more than 15000 neurosurgical procedures.

NEUROSURGEON, PINE SURGEON, TRAUMATIC BRAIN INJURY, SPINE MINIMALLY INVASIVE SURGERY, ENDOSCOPIC SPINE SURGERY, SKULL BASE SURGERY, BRAIN TUMOURS

PRIMARY LOCATION 

DEPT OF NEUROSURGERY

ADDRESS

Sevenhills Hospital ,Ramnagar
Visakhapatnam
Andhra Pradesh
Contact Person : Niranjan 9032777888

Working Hours

    Every Day:10:00 AM - 12:00 PM/ 01:00 PM - 05:15 PM

Book Physical Clinic Appointment

EDUCATION

  • DNB - NATIONAL BOARD - 1996
  • MNAMS - NATIONAL ACADEMY OF MEDICAL SCIENCES - 1996
  • FELLOW OF AMERICAN COLLEGE OF SURGEONS - AMERICAN COLLEGE OF SURGEONS - 2012
  • FELLOW OF INTERNATIONAL COLLEGE OF SURGEONS - INTERNATIONAL COLLEGE OF SURGEONS - 2011
  • FELLOW OF SPINE SURGERY - THE CATHOLIC UNIVERSITY OF SOUTH KOREA - 2009
  • FELLOW OF MINIMALLY INVASIVE NEUROSURGERY - ST RADBOUND UNIVERSITY, HOLLAND - 2004
  • FELLOW OF MICRONEUROSURGERY - FUJITA HEALTH UNIVERSITY - 1998
  • INTERNATIONAL OBSERVER SPINAL SURGERY - CLEVELAND CLINIC,CENTER FOR SPINE HEALTH,USA - 2008
  • MBBS - MKCG MEDICAL COLLEGE, BERHAMPUR - 1990

AWARDS AND RECOGNITIONS

  • 1997 - 1.Dr. Vyagreshwarudu Talent Gold Medal for young scientists [1997], IMA Visakhapatnam
  • 1997 - 1.Dr. V Sri Venkateswara Institute of Medical Sciences best paper award and Fellowship at APNSA annual conference, Vijayawada

PUBLICATIONS

  • 2018 -  Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery Michelle M. Graham, MD; Daniel I. Sessler, MD; Joel L. Parlow, MD, MSc; Bruce M. Biccard, MBChB, MMedSci, PhD; Gordon Guyatt, MD, MSc; Kate Leslie, MBBS, MD, MEpi; Matthew T.V. Chan, MBBS, PhD; Christian S. Meyhoff, MD, PhD; Denis Xavier, MD, MSc; Alben Sigamani, MBBS, MD; Priya A. Kumar, MD; Marko Mrkobrada, MD, MSc; Deborah J. Cook, MD, MSc; Vikas Tandon, MD; Jesus Alvarez-Garcia, MD, PhD; Juan Carlos Villar, MD, PhD; Thomas W. Painter, MBChB; Giovanni Landoni, MD; Edith Fleischmann, MD; Andre Lamy, MD, MSc; Richard Whitlock, MD, PhD; Yannick Le Manach, MD, PhD; Meylin Aphang-Lam, MD; Juan P. Cata, MD; Peggy Gao, MSc; Nicolaas C.S. Terblanche, MD, MMed; Pamidimukkala V. Ramana, MBBS; Kim A. Jamieson, MBChB; Amal Bessissow, MD, MSc; Gabriela R. Mendoza, MD; Silvia Ramirez, MD; Pierre A. Diemunsch, MD, PhD; Salim Yusuf, MD, DPhil; and P.J. Devereaux, MD, PhD Annals of Internal Medcine. 2018 Feb 20;168(4):237-244. doi: 10.7326/M17-2341.
  • 2017 -  Primary pituitary tubercular abscess as a differential diagnosis for sellar suprasellar mass. Pamidimukkala V1, Sahebrao Mandwe D1, K SR1, Batsala H1. British J Neurosurgery. 2017 Jul 25:1-2.
  • 2011 -  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2.
  • 2010 -  The CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized ,placebo-controlled trial. Lancet 2010; 376: 23"32.
  • 2008 -  Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. MRC CRASH Trial Collaborators, Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S. BMJ. 2008 Feb 23; 336(7641):425-9. Epub 2008 Feb 12
  • 2004 -  CRASH Trial Collaborators. Effect of intravenous corticosteroids on death within14 days in 10,008 adults with clinically significant head injury (MRC CRASH Trial): a randomised placebo-controlled trial. Lancet 2004; 364: 1321"28.
  • 2008 -  POISE Study Group; Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 May 31; 371(9627):1839-47.
  • 2006 - POISE Trial Investigators; Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, Choi P, Giles JW, Yusuf S. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing non-cardiac surgery. Am Heart J. 2006 Aug;152(2):223-30

LANGUAGES KNOWN

  • English
  • Telugu
  • Tamil
  • Odia
  • Bengali
  • Hindi

Virtual Clinic